527 related articles for article (PubMed ID: 18281126)
1. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S
J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
Palaska E; Aydin F; Uçar G; Erol D
Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
[TBL] [Abstract][Full Text] [Related]
8. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
[TBL] [Abstract][Full Text] [Related]
9. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cardia MC; Distinto S
J Med Chem; 2007 Feb; 50(4):707-12. PubMed ID: 17253676
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Yáñez M; Vitali A; Ortuso F; Alcaro S
Bioorg Med Chem Lett; 2010 Nov; 20(22):6479-82. PubMed ID: 20934874
[TBL] [Abstract][Full Text] [Related]
13. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.
Gökhan-Kelekçi N; Yabanoğlu S; Küpeli E; Salgin U; Ozgen O; Uçar G; Yeşilada E; Kendi E; Yeşilada A; Bilgin AA
Bioorg Med Chem; 2007 Sep; 15(17):5775-86. PubMed ID: 17611112
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
16. Enantiomers of C(5)-chiral 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives: Analytical and semipreparative HPLC separation, chiroptical properties, absolute configuration, and inhibitory activity against monoamine oxidase.
Cirilli R; Ferretti R; Gallinella B; Turchetto L; Bolasco A; Secci D; Chimenti P; Pierini M; Fares V; Befani O; La Torre F
Chirality; 2004 Nov; 16(9):625-36. PubMed ID: 15382204
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V
Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase.
Maccioni E; Alcaro S; Orallo F; Cardia MC; Distinto S; Costa G; Yanez M; Sanna ML; Vigo S; Meleddu R; Secci D
Eur J Med Chem; 2010 Oct; 45(10):4490-8. PubMed ID: 20702005
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and monoamine oxidase inhibitory activities of some 3-(4-fluorophenyl)-5-aryl-n-substituted-4,5-dihydro-(1H)-pyrazole-1-carbothioamide derivatives.
Koç GŞ; Tan OU; Uçar G; Yildirim E; Erol K; Palaska E
Drug Res (Stuttg); 2014 Nov; 64(11):591-8. PubMed ID: 24452523
[TBL] [Abstract][Full Text] [Related]
20. Development of selective and reversible pyrazoline based MAO-B inhibitors: virtual screening, synthesis and biological evaluation.
Mishra N; Sasmal D
Bioorg Med Chem Lett; 2011 Apr; 21(7):1969-73. PubMed ID: 21377879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]